Related Experiment Video
Updated: Dec 14, 2025

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
Myc-mediated SDHA acetylation triggers epigenetic regulation of gene expression and tumorigenesis
Shi-Ting Li1, De Huang1, Shengqi Shen1
1Division of Molecular Medicine, Hefei National Laboratory for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, China.
Abstract:
The transcriptional role of cMyc (or Myc) in tumorigenesis is well appreciated; however, it remains to be fully established how extensively Myc is involved in the epigenetic regulation of gene expression. Here, we show that by deactivating succinate dehydrogenase complex subunit A (SDHA) via acetylation, Myc triggers a regulatory cascade in cancer cells that leads to H3K4me3 activation and gene expression. We find that Myc facilitates the acetylation-dependent deactivation of SDHA by activating the SKP2-mediated degradation of SIRT3 deacetylase. We further demonstrate that Myc inhibition of SDH-complex activity leads to cellular succinate accumulation, which triggers H3K4me3 activation and tumour-specific gene expression. We demonstrate that acetylated SDHA at Lys 335 contributes to tumour growth in vitro and in vivo, and we confirm increased tumorigenesis in clinical samples. This study illustrates a link between acetylation-dependent SDHA deactivation and Myc-driven epigenetic regulation of gene expression, which is critical for cancer progression.
Insights
The oncogene Myc drives cancer by deacetylating succinate dehydrogenase complex subunit A (SDHA), leading to epigenetic changes and tumor growth. This study reveals a novel Myc-driven acetylation pathway critical for cancer progression.
Area of Science:
- Molecular Biology
- Cancer Epigenetics
- Oncology
Background:
- The transcription factor c-Myc (Myc) is a key driver of tumorigenesis.
- Myc's role in epigenetic regulation of gene expression is not fully understood.
- Succinate dehydrogenase complex subunit A (SDHA) is involved in cellular metabolism.
Purpose of the Study:
- To elucidate the role of Myc in epigenetic regulation via SDHA acetylation.
- To investigate the mechanism by which Myc influences H3K4me3 activation and gene expression.
- To determine the contribution of acetylated SDHA to tumor growth and clinical outcomes.
Main Methods:
- Investigated Myc-mediated acetylation and degradation of SDHA.
- Assessed the impact of SDHA deactivation on succinate levels and H3K4me3 activation.
- Utilized in vitro and in vivo models, along with analysis of clinical samples.
Main Results:
- Myc promotes acetylation-dependent deactivation of SDHA by activating SKP2-mediated SIRT3 degradation.
- Inhibition of SDHA activity by Myc leads to succinate accumulation, activating H3K4me3 and tumor-specific gene expression.
- Acetylated SDHA at Lys 335 is crucial for tumor growth, with increased tumorigenesis observed in clinical samples.
Conclusions:
- Myc hijacks cellular metabolism and epigenetic machinery through SDHA acetylation.
- This study reveals a novel acetylation-dependent mechanism linking Myc to H3K4me3 activation and cancer progression.
- Targeting this pathway may offer new therapeutic strategies for Myc-driven cancers.
More Related Videos
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
07:20Author Spotlight: Epigenetic Modifications and Metabolic Rewiring as Targets for Cancer Therapy
Published on: October 18, 2024
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Histone Modification